RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+23.44%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$756M
AUM Growth
+$756M
(-22%)
Cap. Flow
-$294M
Cap. Flow
% of AUM
-38.88%
Top 10 Holdings %
Top 10 Hldgs %
80.1%
Holding
36
New
5
Increased
2
Reduced
13
Closed
10
Top Buys
| 1 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$50.1M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
$24.4M |
| 3 |
Akebia Therapeutics
AKBA
|
$16.6M |
| 4 |
SCYNEXIS
SCYX
|
$6.74M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
$3.65M |
Top Sells
| 1 |
Prothena Corp
PRTA
|
$59.6M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$51.2M |
| 3 |
Sangamo Therapeutics
SGMO
|
$37.1M |
| 4 |
Arrowhead Research
ARWR
|
$33.4M |
| 5 |
PTC Therapeutics
PTCT
|
$25.7M |
Sector Composition
| 1 | Healthcare | 79.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATHE
26
Alterity Therapeutics
ATHE
$75.1M
| – | – |
0
| – | – |
|
27
Gilead Sciences
GILD
$140B
| – | – |
0
| – | – |
|
28
MEI Pharma
MEIP
$149M
| – | – |
-20,417
| Closed | -$4.55M |
|
29
MacroGenics
MGNX
$121M
| – | – |
-199,398
| Closed | -$5.55M |
|
|
30
Prothena Corp
PRTA
$452M
| – | – |
-1,554,918
| Closed | -$59.6M |
|
|
31
PTC Therapeutics
PTCT
$4.41B
| – | – |
-981,761
| Closed | -$25.7M |
|
|
MRTX
32
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-656,767
| Closed | -$12.5M |
|
|
FLXN
33
DELISTED
Flexion Therapeutics, Inc.
FLXN
| – | – |
-450,000
| Closed | -$7.4M |
|
|
TSRO
34
DELISTED
TESARO, Inc.
TSRO
| – | – |
-700,000
| Closed | -$20.6M |
|
|
ITMN
35
DELISTED
INTERMUNE INC
ITMN
| – | – |
-300,801
| Closed | -$10.1M |
|
|
DSCI
36
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| – | – |
-1,339,039
| Closed | -$17M |
|